TABLE 3

ICC Assessing Between-Site Variability in the Use of Tests and Treatments Given to Children With Bronchiolitis Who Received Intensive Care, With and Without Adjustment For Children’s Characteristics

Test and TreatmentVisitAdjusted for Site Random Effects OnlyAdjusted for Site Random Effects and Children’s Characteristicsa
ICC (%)95% CIICC (%)95% CI
CBCPreadmission or inpatient24.29.3–49.920.77.1–47.2
CXRPreadmission or inpatient17.14.8–45.611.82.2–43.6
Nebulized bronchodilatorsPreadmission0.50.0–98.70.0NC
Nebulized bronchodilatorsInpatient8.42.6–24.16.41.3–26.5
CorticosteroidsPreadmission17.44.8–46.510.81.3–53.4
CorticosteroidsInpatient0.80.0–60.80.00.0–100
AntibioticsPreadmission9.72.9–28.18.82.3–28.4
AntibioticsInpatient0NC0.70.0–96.53
CPAPInpatient27.912.3–51.624.69.3–51.0
IntubationInpatient14.84.2–40.67.61.1–36.8
CPAP and/or intubationInpatient21.38.9–42.720.98.2–43.9
HFNCInpatient42.522.6–65.144.724.0–67.4
  • CXR, chest radiograph; NC, not calculable.

  • a Age, gender, race, insurance, median household income according to zip code, RDSS, and presence of apnea.